Figure 1From: Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazoleThe distribution of trough plasma NVP levels among the study groups.Back to article page